2m 2m 2m 2m 2m 2m 2m
FORTRESS BIOTCH (FBIO)
NASDAQ
$3.21+$0.04 (+1.42%)
Price as of Jun 23, 2026 7:23 PM EDT- $102.3MMarket Cap
- 76.54%1-Year Change
- BiotechnologyIndustry
FORTRESS BIOTCH (FBIO)
$3.21+$0.04 (+1.42%)
FBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.16 | ||
Change | +$0.08 (+2.60%) | ||
Open | $3.05 | ||
High | $3.24 | ||
Low | $3.01 | ||
Previous Close | $3.08 | ||
Volume | 791,591 | ||
30-Day Average Volume | 471,393 | ||
1-Week Change | 7.85% | ||
1-Month Change | 15.33% | ||
1-Year Change | 76.54% | ||
3-Year Change | -63.57% | ||
5-Year Change | -94.23% | ||
Fundamentals | |||
Shares Outstanding | 33.2M | ||
Total Assets | $356.9M | ||
Market Cap | $102.3M | ||
Enterprise Value | -$114.1M | ||
Period: QTR TTM FY | |||
Revenue | $16.0M | ||
Net Income | $110.4M | ||
Free Cash Flow | $203.9M | ||
EBIT | $117.8M | ||
EBITDA | $119.0M | ||
Net Working Capital | $192.1M | ||
EPS | $2.82 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | -7 | ||
P/B | 1 | ||
P/E | 1 | ||
PEG | 0 | ||
Price/Free Cash Flow | 1 | ||
Price/Operating Cash Flow | 1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 10/10/2023 | ||
Earnings & Revenue